These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16385809)

  • 1. Distribution of Neoparamoeba sp. in sediments around marine finfish farming sites in Tasmania.
    Crosbie PB; Macleod C; Forbes S; Nowak BF
    Dis Aquat Organ; 2005 Nov; 67(1-2):61-6. PubMed ID: 16385809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoparamoeba perurans n. sp., an agent of amoebic gill disease of Atlantic salmon (Salmo salar).
    Young ND; Crosbie PB; Adams MB; Nowak BF; Morrison RN
    Int J Parasitol; 2007 Nov; 37(13):1469-81. PubMed ID: 17561022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured gill-derived Neoparamoeba pemaquidensis fails to elicit amoebic gill disease (AGD) in Atlantic salmon Salmo salar.
    Morrison RN; Crosbie PB; Cook MT; Adams MB; Nowak BF
    Dis Aquat Organ; 2005 Sep; 66(2):135-44. PubMed ID: 16231639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of anti-Neoparamoeba sp. antibodies in Tasmanian cultured Atlantic salmon, Salmo salar L.
    Gross K; Carson J; Nowak B
    J Fish Dis; 2004 Feb; 27(2):81-8. PubMed ID: 15009249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18S ribosomal DNA-based PCR identification of Neoparamoeba pemaquidensis, the agent of amoebic gill disease in sea-farmed salmonids.
    Wong FY; Carson J; Elliott NG
    Dis Aquat Organ; 2004 Jul; 60(1):65-76. PubMed ID: 15352525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoparamoeba perurans is a cosmopolitan aetiological agent of amoebic gill disease.
    Young ND; Dyková I; Snekvik K; Nowak BF; Morrison RN
    Dis Aquat Organ; 2008 Jan; 78(3):217-23. PubMed ID: 18380220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in antigenic profile during culture of Neoparamoeba sp., causative agent of amoebic gill disease in Atlantic salmon.
    Villavedra M; McCarthy K; To J; Morrison R; Crosbie P; Broady K; Raison RL
    Int J Parasitol; 2005 Nov; 35(13):1417-23. PubMed ID: 16102771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questionnaire-based risk assessment for amoebic gill disease (AGD) and evaluation of freshwater bathing efficacy of reared Atlantic salmon Salmo salar.
    Douglas-Helders GM; Saksida S; Nowak BF
    Dis Aquat Organ; 2005 Feb; 63(2-3):175-84. PubMed ID: 15819433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of laboratory-based amoebic gill disease revisited.
    Morrison RN; Crosbie PB; Nowak BF
    J Fish Dis; 2004 Aug; 27(8):445-9. PubMed ID: 15291786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross pathology and its relationship with histopathology of amoebic gill disease (AGD) in farmed Atlantic salmon, Salmo salar L.
    Adams MB; Ellard K; Nowak BF
    J Fish Dis; 2004 Mar; 27(3):151-61. PubMed ID: 15009241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration effects of Winogradskyella sp. on the incidence and severity of amoebic gill disease.
    Embar-Gopinath S; Crosbie P; Nowak BF
    Dis Aquat Organ; 2006 Nov; 73(1):43-7. PubMed ID: 17240751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of short-term fallowing as a strategy for the management of recurring organic enrichment under salmon cages.
    Macleod CK; Moltschaniwskyj NA; Crawford CM
    Mar Pollut Bull; 2006 Nov; 52(11):1458-66. PubMed ID: 16828119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atlantic salmon, Salmo salar L., previously infected with Neoparamoeba sp. are not resistant to re-infection and have suppressed phagocyte function.
    Gross KA; Morrison RN; Butler R; Nowak BF
    J Fish Dis; 2004 Jan; 27(1):47-56. PubMed ID: 14986939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential pathology after initial freshwater bath treatment for amoebic gill disease in cultured Atlantic salmon, Salmo salar L.
    Adams MB; Nowak BF
    J Fish Dis; 2004 Mar; 27(3):163-73. PubMed ID: 15009242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental amoebic gill disease of Atlantic salmon, Salmo salar L.: further evidence for the primary pathogenic role of Neoparamoeba sp. (Page, 1987).
    Adams MB; Nowak BF
    J Fish Dis; 2004 Feb; 27(2):105-13. PubMed ID: 15009252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustainable impact of mussel farming in the Adriatic Sea (Mediterranean Sea): evidence from biochemical, microbial and meiofaunal indicators.
    Danovaro R; Gambi C; Luna GM; Mirto S
    Mar Pollut Bull; 2004 Aug; 49(4):325-33. PubMed ID: 15341827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial community shifts in organically perturbed sediments.
    Bissett A; Burke C; Cook PL; Bowman JP
    Environ Microbiol; 2007 Jan; 9(1):46-60. PubMed ID: 17227411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral L-cysteine ethyl ester (LCEE) reduces amoebic gill disease (AGD) in Atlantic salmon Salmo salar.
    Roberts SD; Powell MD
    Dis Aquat Organ; 2005 Aug; 66(1):21-8. PubMed ID: 16175964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of salmonid gill bacteria on development and severity of amoebic gill disease.
    Embar-Gopinath S; Butler R; Nowak B
    Dis Aquat Organ; 2005 Nov; 67(1-2):55-60. PubMed ID: 16385808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of environmental factors on the distribution of Neoparamoeba pemaquidensis in Tasmania.
    Douglas-Helders M; Nowak B; Butler R
    J Fish Dis; 2005 Oct; 28(10):583-92. PubMed ID: 16302952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.